Cotización y Noticias de Glaxosmithkline Plc (GSK.L)

Mínimo/Máximo 24 Horas

Mínimo/Máximo 52 Semanas

#News for #investors and #media: In partnership with @Vir_Biotech, we’re announcing that the @EMA_News is starting a review of a potential new monoclonal antibody therapy for #COVID19.

Learn more about our response to the pandemic: https://gsk.to/2QuCz5H

Our industry continues to work tirelessly to combat the #COVID19 pandemic and the rapid spread of new variant strains.

Go #BehindTheScience to find out how we’re using our science to fight against these viruses both now and into the future.

Cargar más…

CHART de Glaxosmithkline Plc (GSK.L)

Noticias de Glaxosmithkline Plc (GSK.L)

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *